EligibleTrials

Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis

Recruiting · NCT06543550 · Interventional (participants receive a specific treatment) · Lead sponsor: Bio Meds Pharmaceutica Ltda

View the official record on ClinicalTrials.gov →
Endometriosis

Interventions studied

Implantable gestrinoneOral Dienogest

What this trial is about

This study aims to evaluate the effects of therapy with implantable Gestrinone compared to oral Dienogest in relieving complaints related to endometriosis.

Who can take part

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

4 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.